The two are among the most researched synergistic combinations in peptide science because they act on separate receptor pathways at the same time
Similarly, patients using GLP-1s to manage diabetes often report sustained blood sugar control, which can reduce the risk of complications such as heart disease and nerve damage
Maintenance and discontinuation SURMOUNT-4, continue vs placebo switch after lead-in to about 20.9% loss: stopping regained about +14% over 52 weeks while continuing lost a further -5.5%
These figures show why the two vials are documented at different per-dose amounts: the 20 mg vial is set up to last far longer per vial
Curr Neuropharmacol 4:233237 Januszewicz E, Pajak B, Gajkowska B, Samluk L, Djavadian R, Hinton B, Nalecz K (2009) Organic cation/carnitine transporter OCTN3 is present in astrocytes and is up-regulated by peroxisome proliferators-activator receptor agonist
Also, one study is evaluating the effect of exenatide once weekly on Parkinsons disease progression by MRI (72)